Steven Boyd, Armistice

Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).

A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied on athletic...
Biotech Stock Review, Dicerna DRNA

Adding Dicerna (DRNA) $3.30 to Watch List.

Adding Dicerna (DRNA) $3.30 to Watch List. How fun would it be to sell a $3.00 idea (IMMU) at $9.00 you got from us and...

Latest article

Rick Rule Symposium – Conference Cheat Sheet

Natural Resource Investing Symposium - Presenter Guide We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...

GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!

What an Entertaining Week! ..and it's only Thursday. LIVE QUOTE (MAY 18TH) (MAY 21ST) So Where Does That Leave us Today? Yes, it was a pleasant surprise to see GeoVax...

Americore (AMCOF) Funding Launched. Looks Like Good Entry Point.

All Systems Go? A recently completed Magnetometer survey sends a strong signal to investors that the company is advancing its project in a disciplined, data-driven...